Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Francisco, CA
NPI
1295822393
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Parnassus Ave # A808
San Francisco, CA, 94143
Phone (415) 353-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
439 services
Medicare patients, 2024
338
Average age 71
Drug cost, 2024
$1.1M
1,520 prescriptions
Company payments, 2025
$21K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lewis S Blevins Jr. was code 99214 (office e&m - established), 298 times for 236 patients. In total Lewis S Blevins Jr. billed 439 services in 10 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 298 | 236 | $73.33 | $22K |
| 99204 Office E&M - New | Facility | 60 | 60 | $104.43 | $6,266 |
| 99442 Telephone Services | Facility | 39 | 34 | $54.18 | $2,113 |
| 99213 Office E&M - Established | Facility | 18 | 16 | $55.43 | $998 |
By year: 2022 $33K for 492 services; 2023 $44K for 693 services; 2024 $32K for 439 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lewis S Blevins Jr. prescribed most often to Medicare patients was Levothyroxine Sodium, with 266 prescriptions and refills. In total Lewis S Blevins Jr. wrote 1,520 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 266 | 730 | 105 | $3,561 |
| Dexamethasone Generic | 232 | 499 | 88 | $1,591 |
| Genotropin Somatropin | 167 | 180 | 34 | $288K |
| Norditropin Flexpro Somatropin | 164 | 178 | 42 | $334K |
| Testosterone Generic | 142 | 173 | 47 | $23K |
| Omnitrope Somatropin | 105 | 125 | 22 | $226K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 71 | 218 | 36 | $4,062 |
| Nutropin Aq Nuspin Somatropin | 48 | 49 | 11 | $81K |
| Cabergoline Generic | 46 | 88 | 18 | $6,431 |
| Testosterone Cypionate Generic | 41 | 57 | 18 | $1,475 |
| Hydrocortisone Generic | 39 | 83 | 18 | $1,538 |
| Synthroid Levothyroxine Sodium | 30 | 72 | Under 11 | $1,851 |
| Liothyronine Sodium Generic | 26 | 62 | 11 | $1,323 |
| Desmopressin Acetate Generic | 25 | 62 | Under 11 | $1,271 |
| Desmopressin Acetate Desmopressin (Nonrefrigerated) | 18 | 25 | Under 11 | $1,788 |
Brand drugs: 681 claims; generic drugs: 747 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lewis S Blevins Jr. $21K ($21K in general payments such as food, travel and fees) from 5 companies. The largest payer was Recordati_rare_diseases_inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.